Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

ISSX North American Meeting 2026

San Francisco, United States | 11 October 2026 - 14 October 2026
Overview

Connect with Quotient Sciences’ experts who will be attending ISSX 27th North American Meeting 2026 taking place in San Francisco, California, October 11–14, 2026.

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project.  

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
Hilton San Francisco Union Square
333 O’Farrell St., CA 94102
San Francisco, United States

Meet our experts:

We look forward to meeting you at ISSX this October.

Jennifer Goldberg

Senior Director, Business Development

Jennifer Goldberg brings over two decades of experience in pharmaceutical business development, with a focus on drug product manuf...

About Jennifer
Iain Shaw

Senior Director, 14C Enabled Drug Development

Iain Shaw has over 30 years of experience in the pharmaceutical industry, including over 15 years focused on 14C-enabled drug deve...

About Iain
Adam Ball

Associate Director, Business Development

Adam Ball has worked at Quotient Sciences for over 7 years, starting in manufacturing in 2018 before moving into the commercial te...

About Adam

More insight from our experts:

Read More
Translational Pharmaceutics, Solubility Enhancement, Modified Release, CRDMO Bridging In Vitro and In Vivo: Solubility Strategies for Modified Release Success
Read More
Translational Pharmaceutics, Phase 1 Trials Advancing Innovation in Male Contraception: A First-in-Human Study Collaboration
Read More
Translational Pharmaceutics, Early Development, Clinical Pharmacology How Translational Pharmaceutics® Enhances Early Development Speed, Safety, and Confidence
Read More
Read More